Cerebrospinal Fluid Biomarkers in Diagnosing Alzheimer’s Disease in Clinical Practice: An Illustration with 3 Case Reports

Cerebrospinal Fluid Biomarkers in Diagnosing Alzheimer’s Disease in Clinical Practice: An Illustration with 3 Case Reports

Analysis of the brain specific biomarkers amyloid β42 (Aβ42) and total tau (t-tau) protein in cerebrospinal fluid (CSF) has a sensitivity and specificity of more than 85% for differentiating Alzheimer’s Disease (AD) from non-demented controls. International guidelines are contradictory in their advi...

Full description

Bibliographic Details
Main Authors: Diane Slats, Petra E. Spies, Magnus J.C. Sjögren, Frans R.J. Verhey, Marcel M. Verbeek, Marcel G.M. Olde Rikkert
Format: Article
Language:English
Published: Karger Publishers 2010-02-01
Series:Case Reports in Neurology
Subjects:
Aβ42
Tau
Cerebrospinal fluid
Dementia
Alzheimer’s disease
Diagnostics
Online Access:http://www.karger.com/Article/FullText/286280

Internet

http://www.karger.com/Article/FullText/286280

Similar Items